Admedus is continuing with its planned divestiture of the Immunotherapies business which involves Star Bright (or a related party of Star Bright) investing $18.0 million into the business for a 60% stake. An additional $500,000 advance was received during the quarterfrom Star Bright (cumulative total of $1,000,000) which is intended to be offset against the proposed $18.0 million consideration.
So maybe they receiving some money into immuno from Star Bright
Admedus is continuing with its planned divestiture of the...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $323.4M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |